Search

ISSN: 2228-5881 eISSN: 2251-7308

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics Indexing Info About APB & Contacts Indexing and Abstracting Articles In Press Archive

Journal Info:

Freq.: Quarterly

eISSN: 2251-7308
pISSN: 2228-5881

Permission: CC By

Platinum Open Access

(no submission or publication fees)

Powered by

Abstracting and Indexing

PubMed Central, Pubmed,

Emerging Sources Citation Index

Scopus, Google Scholar,

EMBASE/Excerpta Medica

EBSCOhost; CAS: DOAJ

SCImago Journal & Country Rank

2024, Vol 14, No. 4

Advanced Pharmaceutical Bulletin (APB) is a peer-reviewed multidisciplinary open access journal, covering a wide range of various integrative fields with Pharmaceutical sciences.
APB is the official journal of Drug Applied Research Center and Faculty of Pharmacy, published by TUOMS PRESS, Tabriz University of Medical Sciences.

Publication Advantages in Advanced Pharmaceutical Bulletin are:

Free of charge publication for all types of articles
Fast and constructive peer review
Easy and quick online submission of manuscripts
Author friendly review
Rapid publication by means of running issue concept, which gives authors the benefit of 'No Waiting Time' for the officially accepted manuscripts
Free publication of color images
Worldwide visibility of papers (Open Access Journal)

Research Article

1. Cefazolin-Loaded Double-Shelled Hollow Mesoporous Silica Nanoparticles/Polycaprolactone Nanofiber Composites: A Delivery Vehicle for Regenerative Purposes

Negar Karimi , Mohsen Khorashadizadeh, Mohammad Yahya Hanafi-Bojd, Esmat Alemzadeh*

Adv Pharm Bull. 2023;13(2): 328-338. doi: 10.34172/apb.2023.032

PMCID: PMC10278221 PMID: 37342378

Article

PDF

Full Text

XML

Cited By:

0

3

Research Article

2. In Vitro Efficacy of Curcumin-Loaded Amine-Functionalized Mesoporous Silica Nanoparticles against MCF-7 Breast Cancer Cells

Zahra Mohebian, Mirzaagha Babazadeh, Nosratollah Zarghami*

Adv Pharm Bull. 2023;13(2): 317-327. doi: 10.34172/apb.2023.035

PMCID: PMC10278223 PMID: 37342377

Article

PDF

Full Text

XML

Cited By:

1

6

Research Article

3. Mesoporous Silica Administration as a New Strategy in the Management of Warfarin Toxicity: An In-Vitro and In-Vivo Study

Fatemeh Farjadian* , Fatemeh Parsi, Reza Heidari , Khatereh Zarkesh, Hamid Reza Mohammadi, Soliman Mohammadi-Samani , Lobat Tayebi

Adv Pharm Bull. 2024;14(4): 883-891. doi: 10.34172/apb.42665

Article

PDF

Suppl 1

XML

Cited By:

0